Page last updated: 2024-09-03

rc 3095 and Disease, Pulmonary

rc 3095 has been researched along with Disease, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrade, CF; De Angelis, K; Malfitano, C; Oliveira-Freitas, VL; Schwartsmann, G; Simoneti, LE; Thomaz, LD; Ulbrich, JM	1

Other Studies

1 other study(ies) available for rc 3095 and Disease, Pulmonary

Article	Year
RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury. BioMed research international, 2015, Volume: 2015 Topics: Animals; Antineoplastic Agents; Bombesin; Disease Models, Animal; Interleukin-1beta; Lung; Lung Diseases; Male; Nitric Oxide Synthase Type III; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bombesin; Reperfusion Injury; Tumor Necrosis Factor-alpha	2015

Article

Year

RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury.

BioMed research international, 2015, Volume: 2015

Topics: Animals; Antineoplastic Agents; Bombesin; Disease Models, Animal; Interleukin-1beta; Lung; Lung Diseases; Male; Nitric Oxide Synthase Type III; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bombesin; Reperfusion Injury; Tumor Necrosis Factor-alpha

2015